CD274 and neoplasm: Therefore, the use of a radiolabelled anti-PD-L1 probe could provide non-invasive information about a tumour’s PD-L1 expression, avoiding biopsies, and could be useful in order to select patients candidates to immunotherapy and to predict the response to treatment [108,109].